Patient-reported Outcomes—An Emerging Cornerstone of Effective Intravenous Immunoglobulin Therapy
US Neurology, 2015;11(1):40–6 DOI: http://doi.org/10.17925/USN.2015.11.01.40
Parkinson’s Disease Psychosis—A Symptom Complex Signaling Risk for Increased Disability and Caregiver Burden
US Neurology, 2015;11(1):23–6 DOI: http://doi.org/10.17925/USN.2015.11.01.23
Multiple Sclerosis (MS) affects 2.3 million people world-wide and is a leading cause of neurological disability. Recent clinical evidence suggests that B cells contribute to both the inflammatory and...
Richard Lewis, MD, FAAN discusses chronic inflammatory demyelinating polyneuropathy (CIPD). Sometimes symptoms of CIDP can closely resemble those of other conditions. In light of this it is important...
In this exclusive interview during WORLDSymposium 2015, Nicholas Clayton, MSc, staff scientist at Genzyme Corporation discusses the exciting new data he and his colleagues presented on antisense...
Kurt Jaeckle, MD, professor of neurology and oncology, Mayo Clinic, discusses radiosurgery versus radiotherapy followed by whole brain radiation for brain metastases.